On October 6, the Neighbourhood Pharmacies provided a submission to the Natural and Non-prescription Health Products Directorate to help to help inform Health Canada’s ongoing policy work to develop an appropriate regulatory pathway for non-prescription health products containing cannabidiol (CBD). Our feedback is grounded in the key recommendation put forth by the Science Advisory Committee on Health Products Containing Cannabis that Cannabis Health Products (CHPs) be available exclusively in pharmacies. Our feedback outlines the key public health and harm reduction role pharmacy can provide for these therapeutic products as well as pharmacy’s flexibility in operationalizing its health oversight role.